Navigation Links
How buckyballs hurt cells
Date:5/27/2008

A new study into the potential health hazards of the revolutionary nano-sized particles known as buckyballs predicts that the molecules are easily absorbed into animal cells, providing a possible explanation for how the molecules could be toxic to humans and other organisms.

Using computer simulations, University of Calgary biochemist Peter Tieleman, post-doctoral fellow Luca Monticelli and colleagues modeled the interaction between carbon-60 molecules and cell membranes and found that the particles are able to enter cells by permeating their membranes without causing mechanical damage. Their results are published in the current Advance Online Publication of Nature Nanotechnology, the worlds leading nanotechnology journal.

Buckyballs are already being made on a commercial scale for use in coatings and materials but we have not determined their toxicity, said Tieleman, a Senior Scholar of the Alberta Heritage Foundation for Medical Research who specializes in membrane biophysics and biocomputing. There are studies showing that they can cross the blood-brain barrier and alter cell functions, which raises a lot of questions about their toxicity and what impact they may have if released into the environment.

Tielemans team used the high-powered computing resources of WestGrid, a partnership between 14 Western Canadian institutions, to run some of the cell behaviour simulations. The resulting model showed that buckyball particles are able to dissolve in cell membranes, pass into cells and re-form particles on the other side where they can cause damage to cells.

Spherical carbon-60 molecules were discovered in 1985, leading to the Nobel Prize in physics for researchers from the University of Sussex and Rice University who named the round, hollow molecules Buckminsterfullerene after renowned American architect Richard Buckminster Fuller, the inventor of the geodesic dome.

Popularly known as buckyballs, carbon-60 molecules form naturally in minute quantities under extreme conditions such as lightning strikes. They can also be produced artificially as spheres or oblong-shaped balls, known as fullerenes, and can be used to produce hollow fibers known as carbon nanotubes. Both substances are considered to be promising materials in the field of nanotechnology because of their incredible strength and heat resistance. Potential applications include the production of industrial materials, drug delivery systems, fuel cells and even cosmetics.

In recent years, much research has focused on the potential health and environmental impacts of buckyballs and carbon nanotubes. Fullerenes have been shown to cause brain damage in fish and inhaling carbon nanotubes results in lung damage similar to that caused by asbestos.

Buckyballs commonly form into clumps that could easily be inhaled by a person as dust particles, Tieleman said. How they enter cells and cause damage is still poorly understood but our model shows a possible mechanism for how this might occur.


'/>"/>

Contact: Grady Semmens
gsemmens@ucalgary.ca
403-220-7722
University of Calgary
Source:Eurekalert

Related biology technology :

1. Video shows buckyballs form by shrink wrapping
2. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
3. Reovirus Infection of Melanoma Cells Generates Anti-Tumour Immunity
4. Scientists synthesize memory in yeast cells
5. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
6. Patent Office Rules in Neuralstems Favor in Dispute with StemCells, Inc.
7. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
8. Scientists synthesize memory in yeast cells
9. Breakthrough research identifies how cells from pigs may cure diabetes
10. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
11. STEM CELLS Journal Names Co-Editors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
Breaking Biology News(10 mins):